12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Neovacs proposes rights offering

Neovacs S.A. (Euronext:ALNEV), Paris, France
Business: Autoimmune, Inflammation, Cancer
Date announced: 2/15/13
Type: Rights...

Read the full 48 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >